Inventor

HELDIN CARL-HENRIK

SE42 patents

⚠️ This page may combine multiple inventors who share the name “HELDIN CARL-HENRIK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HELDIN CARL-HENRIK

LUDWIG INST CANCER RES

Isolated, large latent complexes of TGF-β2 and TGF-β3, and new binding protein for latent form TGF-β1, TGF-β2 and TGF-β3 LTBP-2

Substantially pure receptor like TGF-β 1 binding molecules and uses thereof

Platelet derived growth factor agonists

Activin receptor-like kinases, proteins having serine threonine kinase domains and polynucleotides encoding same

Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding them

Isolated, large latent complexes of TGF-β2 and TGF-β3, and new binding protein for latent form TGF-β1, TGF-β2 and TGF-β3 LTBP-2

Method for identifying compounds that affect Smad7 binding

Isolated nucleic acid molecules encoding Smad7

Isolated nucleic acid encoding receptor-like TGF-β1 binding protein

Platelet-derived growth factor D

Isolated nucleic acid molecules which encode activin-receptor like kinases, expression vectors and cells containing these

DNA encoding platelet derived endothelial cell growth factor (PD-ECGF)

Antibodies which bind specifically to activin receptor like kinases

Antibodies which bind specifically to activin receptor-like kinases

Activin like receptor--Isolated kinase proteins ALK-2, ALK-4, ALK-5, and nucleic acid molecules encoding them

Peptides derived from endothelial cell growth factor

Smad2 phosphorylation and interaction with Smad4

Platelet derived growth factor antagonists

Isolated nucleotide sequence expressing human transforming growth factor-β1-binding protein

Nucleotide sequences for novel protein tyrosine phosphatases

Smad associating polypeptides

Nucleic acids coding for GLM-2, a novel protein tyrosine phosphatase

Activin receptor-like kinase-1 proteins having serine-threonine kinase domains

Smad2 phosphorylation and interaction with Smad4

PARG, a GTPase activating protein which interacts with PTPL1

Isolated nucleic acid molecules encoding PARG, a GTPase activating protein which interacts with PTPL1

CHIRON CORP

Recombinant DNA encoding PDGF A-chain polypeptide and expression vectors

Recombinant DNA encoding PDGF A-chain polypeptides

Recombinant PDGF A-chain homodimers and methods of use

GILEAD SCIENCES INC

Method for treatment of tumors using nucleic acid ligands to PDGF

Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor

CURIS INC

Methods of identifying morphogen receptor-binding analogs

Morphogenic protein-specific cell surface receptors and uses therefor

ANDERSSON LEIF

Methods and materials related to hair pigmentation and cancer

Methods and materials related to grey alleles

CREATIVE BIOMOLECULES INC

Methods of antagonizing OP-1 binding to a cell surface receptor utilizing ALK polypeptides

LICENTIA LTD

Platelet-derived growth factor D, DNA coding therefor, and uses thereof

NOVARTIS AG

Combination comprising a signal transduction inhibitor and an epothilone derivative

THE UNIV OF TOKYO

Therapeutic and prophylactic agent for glioma, brain tumor malignancy marker, brain tumor prognostic marker, method for determining malignancy and prognosis of brain tumor and antibody inhibiting tumor proliferation

MIYAZONO KOHEI

Antibodies which bind specifically to activin receptor like kinase 3

LUDWIG INSTITIUTE FOR CANCER R

Combination for the treatment of endothelial damage

LANDSTROM MARENE INGA-BRITT

Cleavage inhibitors of transforming growth factor beta type I receptor and uses thereof in cancer therapy